[HTML][HTML] IL-1β, IL-6, TNF-α and CRP in elderly patients with depression or Alzheimer's disease: systematic review and meta-analysis

A Ng, WW Tam, MW Zhang, CS Ho, SF Husain… - Scientific reports, 2018 - nature.com
We carried out systematic review and meta-analysis to evaluate whether peripheral levels of
pro-inflammatory markers including Interleukin-1 beta (IL-1β), Interleukin-6 (IL-6), Tumor …

Inflammatory markers in Alzheimer's disease and mild cognitive impairment: a meta-analysis and systematic review of 170 studies

XN Shen, LD Niu, YJ Wang, XP Cao, Q Liu… - Journal of Neurology …, 2019 - jnnp.bmj.com
Objective Inflammation plays a crucial role in the pathogenesis of mild cognitive impairment
(MCI) and Alzheimer's disease (AD). Our study aimed to analyse previous inconsistent …

Peripheral inflammatory markers in Alzheimer's disease: a systematic review and meta-analysis of 175 studies

KSP Lai, CS Liu, A Rau, KL Lanctôt… - Journal of Neurology …, 2017 - jnnp.bmj.com
Objectives Increasing evidence suggests that inflammation is involved in Alzheimer's
disease (AD) pathology. This study quantitatively summarised the data on peripheral …

[HTML][HTML] Role of inflammatory markers in the diagnosis of vascular contributions to cognitive impairment and dementia: a systematic review and meta-analysis

C Custodero, A Ciavarella, F Panza, D Gnocchi… - Geroscience, 2022 - Springer
Vascular contribution to cognitive impairment and dementia (VCID) is a clinical label
encompassing a wide range of cognitive disorders progressing from mild to major vascular …

Neuroinflammation in Alzheimer's disease

F Zhang, L Jiang - Neuropsychiatric disease and treatment, 2015 - Taylor & Francis
Amyloid-β plaques and neurofibrillary tangles are the main neuropathological hallmarks in
Alzheimer's disease (AD), the most common cause of dementia in the elderly. However, it …

[HTML][HTML] Association of inflammation and cognition in the elderly: a systematic review and meta-analysis

S Leonardo, F Fregni - Frontiers in Aging Neuroscience, 2023 - frontiersin.org
Background The development of mild cognitive impairment (MCI) and Alzheimer's disease
(AD) may be associated with an inflammatory process. Inflammatory cytokines may be a …

[HTML][HTML] Association of pro-inflammatory diet with increased risk of all-cause dementia and Alzheimer's dementia: a prospective study of 166,377 UK Biobank …

Y Shi, F Lin, Y Li, Y Wang, X Chen, F Meng, Q Ye… - BMC medicine, 2023 - Springer
Background Increasing evidence suggests an association between pro-inflammatory diets
and cognitive function. However, only a few studies based on small sample sizes have …

[HTML][HTML] The potential of the gut microbiome for identifying Alzheimer's disease diagnostic biomarkers and future therapies

Y Zhan, M Al-Nusaif, C Ding, L Zhao… - Frontiers in …, 2023 - frontiersin.org
Being isolated from the peripheral system by the blood–brain barrier, the brain has long
been considered a completely impervious tissue. However, recent findings show that the gut …

Serum tumour necrosis factor‐α and interleukin‐6 levels in Alzheimer's disease and mild cognitive impairment

YS Kim, KJ Lee, H Kim - Psychogeriatrics, 2017 - Wiley Online Library
Background Neuroinflammation has been recognized as a feature of Alzheimer's disease
(AD), and mild cognitive impairment (MCI) is believed to share several pathological features …

[HTML][HTML] Machine learning and artificial intelligence in therapeutics and drug development life cycle

S Borkotoky, A Joshi, V Kaushik… - Drug Development Life …, 2022 - intechopen.com
In recent years, the pharmaceutical business has seen a considerable increase in data
digitization. With digitization, however, comes the challenge of obtaining, analyzing, and …